Climb Bio, Inc. CLYM
9.12 USD +0.25 (+2.82%)
Nov 6, 2026, 9:47 AM EST
8.88 Day range 9.04
1.64 52-week range 18.33
- YTD
- +128.00%
- 1 year
- +367.69%
Financial health
Altman Z-Score
34.09 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -4.5×
FY 2019 5y median -4.5× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 1.7×
FY 2019 5y median 1.6× FY 2025
P/FCF -5.0×
FY 2019 5y median -5.5× FY 2025
EV/EBITDA -4.0×
FY 2019 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -20.1%
FY 2019 5y median -18.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -37.3%
FY 2019 5y median -34.9% FY 2025
ROIC -42.2%
FY 2019 5y median -37.3% FY 2025
ROA -35.7%
FY 2019 5y median -33.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 17.2%
FY 2019 FY 2025
EPS (diluted) 42.5%
FY 2019 FY 2025
Free Cash Flow -250.5%
FY 2019 FY 2025
Financial Health
Current Ratio 15.2×
FY 2019 5y median 24.6× FY 2025
Quick Ratio 15.2×
FY 2019 5y median 24.6× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.6×
FY 2019 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31